KD Logo

Recent Insider Activity Could Benefit Arbutus Biopharma Corp (ABUS)

NUE

In a filing, Arbutus Biopharma Corp revealed its Chief Financial Officer HASTINGS DAVID C unloaded Company’s shares for reported $72827.0 on Feb 04 ’25. In the deal valued at $3.28 per share,22,183 shares were sold. As a result of this transaction, HASTINGS DAVID C now holds 159,724 shares worth roughly $0.55 million.

Then, Sims Karen sold 19,348 shares, generating $63,519 in total proceeds. Upon selling the shares at $3.28, the Chief Medical Officer now owns 106,194 shares.

Before that, McElhaugh Michael J. sold 23,790 shares. Arbutus Biopharma Corp shares valued at $78,103 were divested by the Interim President & CEO at a price of $3.28 per share. As a result of the transaction, McElhaugh Michael J. now holds 1,481,003 shares, worth roughly $5.11 million.

Jefferies upgraded its Arbutus Biopharma Corp [ABUS] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late February with a ‘”a Hold”‘ rating. H.C. Wainwright began covering ABUS with “Buy” recommendation on December 17, 2020.

Price Performance Review of ABUS

On Tuesday, Arbutus Biopharma Corp [NASDAQ:ABUS] saw its stock jump 3.29% to $3.45. Over the last five days, the stock has gained 2.68%. Arbutus Biopharma Corp shares have risen nearly 5.50% since the year began. Nevertheless, the stocks have risen 18.56% over the past one year. While a 52-week high of $4.72 was reached on 02/25/25, a 52-week low of $2.30 was recorded on 01/13/25. SMA at 50 days reached $3.33, while 200 days put it at $3.57.

Levels Of Support And Resistance For ABUS Stock

The 24-hour chart illustrates a support level at 3.33, which if violated will result in even more drops to 3.22. On the upside, there is a resistance level at 3.63. A further resistance level may holdings at 3.82. The Relative Strength Index (RSI) on the 14-day chart is 55.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.02, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 53.76%. Stochastics %K at 43.35% indicates the stock is a holding.

Most Popular